JP2007535492A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535492A5
JP2007535492A5 JP2006542675A JP2006542675A JP2007535492A5 JP 2007535492 A5 JP2007535492 A5 JP 2007535492A5 JP 2006542675 A JP2006542675 A JP 2006542675A JP 2006542675 A JP2006542675 A JP 2006542675A JP 2007535492 A5 JP2007535492 A5 JP 2007535492A5
Authority
JP
Japan
Prior art keywords
virus
conjugate
antigen
antibody
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006542675A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007535492A (ja
JP4912153B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/040046 external-priority patent/WO2005084179A2/en
Publication of JP2007535492A publication Critical patent/JP2007535492A/ja
Publication of JP2007535492A5 publication Critical patent/JP2007535492A5/ja
Application granted granted Critical
Publication of JP4912153B2 publication Critical patent/JP4912153B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006542675A 2003-12-01 2004-12-01 タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法 Expired - Fee Related JP4912153B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52604403P 2003-12-01 2003-12-01
US60/526,044 2003-12-01
PCT/US2004/040046 WO2005084179A2 (en) 2003-12-01 2004-12-01 Improved method for preparing conjugates of proteins and chelating agents

Publications (3)

Publication Number Publication Date
JP2007535492A JP2007535492A (ja) 2007-12-06
JP2007535492A5 true JP2007535492A5 (https=) 2011-06-16
JP4912153B2 JP4912153B2 (ja) 2012-04-11

Family

ID=34919313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006542675A Expired - Fee Related JP4912153B2 (ja) 2003-12-01 2004-12-01 タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法

Country Status (4)

Country Link
US (1) US7259249B2 (https=)
EP (2) EP2962699A3 (https=)
JP (1) JP4912153B2 (https=)
WO (1) WO2005084179A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877901B2 (en) 2002-12-13 2014-11-04 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US7591994B2 (en) 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US7524570B2 (en) * 2005-10-13 2009-04-28 Hitachi Global Storage Technologies Netherlands B.V. Perpendicular magnetic recording system and medium with high-moment corrosion-resistant “soft” underlayer (SUL)
JP5730581B2 (ja) 2008-01-08 2015-06-10 ランセウス メディカル イメージング, インコーポレイテッド 造影剤としてのn−アルコキシアミド抱合体
US20100247484A1 (en) * 2009-03-31 2010-09-30 Heinrich Barchet Combination therapy of an afucosylated antibody and one or more of the cytokines gm csf, m csf and/or il3
WO2011005322A2 (en) * 2009-07-08 2011-01-13 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
ES2978177T3 (es) 2009-12-02 2024-09-06 Immunomedics Inc Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
NO331080B1 (no) * 2010-01-29 2011-09-26 Nordic Nanovector As Radioimmunkonjugater, farmasøytiske sammensetninger og kit omfattende det samme og anvendelse derav
LT2535358T (lt) * 2010-02-10 2018-03-26 Fujifilm Ri Pharma Co., Ltd. Radioaktyvus metalu žymėtas anti-kadherino antikūnas
US10363323B2 (en) 2011-02-10 2019-07-30 Ruprecht-Karls-Universitat Heidelberg Hydrophobic modified peptides for liver specific diagnosis
CA2898146C (en) * 2012-12-19 2020-12-01 Charles Andrew BOSWELL Methods and compositions for radiohalogen protein labeling
EP3010549A4 (en) * 2013-06-17 2017-03-15 Emory University Pathogen binding agents conjugated to radioisotopes and uses in imaging and therapeutic applications
EP2873679A1 (en) * 2013-11-13 2015-05-20 F.Hoffmann-La Roche Ag Camelid single-domain antibody directed against amyloid bêta and methods for producing conjugates thereof
AU2016252771B2 (en) 2015-04-22 2021-12-16 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
WO2017161356A1 (en) * 2016-03-18 2017-09-21 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
MY206158A (en) 2017-05-24 2024-12-02 Novartis Ag Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer
CA3148288A1 (en) * 2019-08-21 2021-02-25 Nihon Medi-Physics Co., Ltd. Method for producing radioactive metal complex
WO2022149578A1 (ja) * 2021-01-08 2022-07-14 日本メジフィジックス株式会社 Ac-225溶液の製造方法およびAc-225溶液を用いた医薬の製造方法
AU2023242087A1 (en) * 2022-03-30 2024-09-12 Nihon Medi-Physics Co., Ltd. Method for producing complex

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US5556982A (en) 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4824986A (en) 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
NZ212437A (en) 1985-06-17 1992-06-25 Mark Philip Best Site-directed antibody conjugates, and their preparation
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
US5271927A (en) 1986-02-13 1993-12-21 Celltech Limited Antibody conjugates with macrocyclic ligands
GB8603537D0 (en) 1986-02-13 1986-03-19 Parker D Conjugate compound
US5082930A (en) 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4861869A (en) 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US5246692A (en) 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5099069A (en) 1986-09-05 1992-03-24 Gansow Otto A Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5057302A (en) 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
WO1988007553A1 (fr) * 1987-03-26 1988-10-06 Teijin Limited Procede de preparation d'un complexe d'anticorps
US5217704A (en) 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5130118A (en) 1987-11-06 1992-07-14 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5612016A (en) 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
US5075099A (en) 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
CA1341373C (en) 1988-06-24 2002-07-02 Roberta C. Cheng Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
US5756065A (en) 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
US5808003A (en) 1989-05-26 1998-09-15 Perimmune Holdings, Inc. Polyaminocarboxylate chelators
US5112953A (en) 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5124471A (en) 1990-03-26 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bifunctional dtpa-type ligand
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5310535A (en) 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
JPH05344899A (ja) 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho C型肝炎ウイルス外被タンパク質の産生法
US5760191A (en) 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
DE69534530T2 (de) 1994-08-12 2006-07-06 Immunomedics, Inc. Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
WO2003048207A2 (en) * 2001-11-28 2003-06-12 Immunomedics, Inc. Anti-dota antibody

Similar Documents

Publication Publication Date Title
JP2007535492A5 (https=)
CA2508831A1 (en) Immunoconjugates with an intracellularly-cleavable linkage
US8038983B2 (en) Fluorinated carbohydrate conjugates
JP4912153B2 (ja) タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法
AU2007343610B2 (en) Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
AU2005211754B2 (en) Therapeutic and diagnostic conjugates for use with multispecific antibodies
JP2020506962A5 (https=)
JP2017149718A5 (https=)
JP2008544755A5 (https=)
JP2011508738A5 (https=)
JP2016006123A5 (https=)
JP2008523083A (ja) 炎症性疾患および免疫調節不全疾患、感染性疾患、病的血管新生およびがんの免疫療法および検出のための方法および組成物
JP2009538284A5 (https=)
JP2007528372A5 (https=)
JP2009521909A5 (https=)
JP2009530345A5 (https=)
JP2016520548A5 (https=)
WO2009114040A3 (en) Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses
JP2020536569A5 (https=)
JP2025539841A5 (https=)
JP2008506816A5 (https=)
JP2000095769A5 (https=)
WO2024107646A8 (en) Anti-cll-1 chimeric antigen receptors, engineered cells and related methods
Baranyai et al. Development of functionalized nanocarriers for drug targeting in tuberculosis
Chin Rare Frameworks.